Journal of Child and Adolescent Psychopharmacology

期刊简介：Journal of Child and Adolescent Psychopharmacology (JCAP) is the premier peer-reviewed journal covering the clinical aspects of treating this patient population with psychotropic medications including side effects and interactions, standard doses, and research on new and existing medications. The Journal includes information on related areas of medical sciences such as advances in developmental pharmacokinetics, developmental neuroscience, metabolism, nutrition, molecular genetics, and more.Journal of Child and Adolescent Psychopharmacology coverage includes:New drugs and treatment strategies including the use of psycho-stimulants, selective serotonin reuptake inhibitors, mood stabilizers, and atypical antipsychoticsNew developments in the diagnosis and treatment of ADHD, anxiety disorders, schizophrenia, autism spectrum disorders, bipolar disorder, eating disorders, along with other disordersReports of common and rare Treatment Emergent Adverse Events (TEAEs) including: hyperprolactinemia, galactorrhea, weight gain/loss, metabolic syndrome, dyslipidemia, switching phenomena, sudden death, and the potential increase of suicide. Outcomes research.

【译文】《儿童和青少年精神药理学杂志》（JCAP）是首屈一指的同行评审期刊，涵盖使用精神药物治疗该患者群体的临床方面，包括副作用和相互作用、标准剂量以及新药和现有药物的研究。该杂志还包括与医学科学相关领域的最新进展，如发育药代动力学、发育神经科学、代谢、营养、分子遗传学等。JCAP的覆盖范围包括：新药和治疗策略，包括使用精神兴奋剂、选择性5-羟色胺再摄取抑制剂、情绪稳定剂和非典型抗精神病药；ADHD、焦虑障碍、精神分裂症、自闭症谱系障碍、双相情感障碍、饮食障碍等疾病的诊断和治疗新进展；常见和罕见的治疗相关不良事件（TEAEs）的报告，包括：高催乳素血症、溢乳、体重增加/减少、代谢综合征、血脂异常、转换现象、突然死亡和自杀风险增加的可能性。结局研究。